Planned website maintenance is taking place from 11:00 pm AEDT on Friday 30 October to 6:00 am AEDT on Saturday 31 October 2026. Some pages may be temporarily unavailable. If issues continue outside this time, please contact us.
Sponsor content
359 result(s) found, displaying 271 to 280
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for GARDASIL 9 Human Papillomavirus 9-valent Vaccine, Recombinant, 30, 40, 60, 40, 20, 20, 20, 20, 20 micrograms/0.5mL, suspension for injection, syringe.
-
Designation or determinationProvisional approval
-
Designation or determinationPriority review
-
Australian Public Assessment Report (AusPAR)Australian Public Assessment Report for Pembrolizumab [Keytruda]
-
Prescription medicine registrationActive ingredients: letermovir.
-
Prescription medicine registrationActive ingredients: pembrolizumab.
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
Cancellation by sponsorRequested by Merck Sharp & Dohme (Australia) Pty Ltd
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for NOXAFIL posaconazole 300 mg/16.7 mL concentrated injection vial.